Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: Retrospective analysis

Table 2 Categorical data of the groups with and without preoperative transarterial chemoembolization treatment

Variables and stratification	TACE (n = 88)	No TACE (n = 116)	χ2	P value
Sex			0.352	0.553
Male	79	101
Female	9	15
MELD			5.269	0.072
< 15	80	104
15-25	5	12
> 25	3	0
Child			0.207	0.902
A	56	77
B	14	18
C	18	21
Operation method			1.874	0.171
CDLT	71	84
LDLT	17	32
AFP			14.141	0.003a
< 20	21	47
≤ 400	22	38
400-1000	18	9
> 1000	27	22
Tumor recurrence			21.983	< 0.001a
No	46	96
Yes	42	20
Complications			3.064	0.382
No	66	97
Complication of bile duct	8	9
Complication of vessel	7	6
Infection	7	4

^aP < 0.05, TACE vs no TACE. TACE: Transarterial chemoembolization; Child: Child-Turcotte-Pugh classification; MELD: Model for end-stage liver disease; AFP: α-fetoprotein; CDLT: Cadaveric donor liver transplantation; LDLT: Living donor liver transplantation.